Glutamate-based Therapies for Psychiatric Disorders

Author:   Phil Skolnick
Publisher:   Birkhauser Verlag AG
ISBN:  

9783034602402


Pages:   178
Publication Date:   09 September 2010
Format:   Hardback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $494.95 Quantity:  
Add to Cart

Share |

Glutamate-based Therapies for Psychiatric Disorders


Add your own review!

Overview

Both metabotropic and ionotropic glutamate receptors present attractive “druggable” targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This “Milestones in Drug Therapy” volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book.

Full Product Details

Author:   Phil Skolnick
Publisher:   Birkhauser Verlag AG
Imprint:   Birkhauser Verlag AG
Dimensions:   Width: 15.50cm , Height: 1.80cm , Length: 23.50cm
Weight:   0.494kg
ISBN:  

9783034602402


ISBN 10:   3034602405
Pages:   178
Publication Date:   09 September 2010
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

N-Methyl-d-Aspartate (NMDA) Antagonists for the Treatment of Depression.- Ionic Glutamate Modulators in Depression (Zinc, Magnesium).- Positive Allosteric Modulation of AMPA Receptors: A Novel Potential Antidepressant Therapy.- Glutamatergic Modulators for the Treatment of Major Depressive Disorder: Metabotropic Glutamate Receptors.- Positive Modulation of AMPA Receptors as a Broad-Spectrum Strategy for Treating Neuropsychiatric Disorders.- Activation of Group II Metabotropic Glutamate Receptors (mGluR2 and mGluR3) as a Novel Approach for Treatment of Schizophrenia.- mGluR1 Negative Allosteric Modulators: An Alternative Metabotropic Approach for the Treatment of Schizophrenia.- Metabotropic Glutamate Receptors as Targets for the Treatment of Drug and Alcohol Dependence.- Metabotropic Approaches to Anxiety.

Reviews

From the reviews: This book summarizes the translational research in the development of glutamate-based approaches to treat psychiatric disorders. Written and edited by an international group of researchers, it is an important addition to the psychiatric literature. ! The intended audience includes psychiatric researchers and psychiatrists. Neuroscientists interested in the treatment of patients with psychiatric disorders also would benefit from reading this book. ! The index is quite helpful. ! presents a unique and novel approach that is desperately needed in the treatment of these difficult disorders. (Michael Joel Schrift, Doody's Review Service, February, 2011)


From the reviews: This book summarizes the translational research in the development of glutamate-based approaches to treat psychiatric disorders. Written and edited by an international group of researchers, it is an important addition to the psychiatric literature. ... The intended audience includes psychiatric researchers and psychiatrists. Neuroscientists interested in the treatment of patients with psychiatric disorders also would benefit from reading this book. ... The index is quite helpful. ... presents a unique and novel approach that is desperately needed in the treatment of these difficult disorders. (Michael Joel Schrift, Doody's Review Service, February, 2011)


From the reviews: This book summarizes the translational research in the development of glutamate-based approaches to treat psychiatric disorders. Written and edited by an international group of researchers, it is an important addition to the psychiatric literature. ... The intended audience includes psychiatric researchers and psychiatrists. Neuroscientists interested in the treatment of patients with psychiatric disorders also would benefit from reading this book. ... The index is quite helpful. ... presents a unique and novel approach that is desperately needed in the treatment of these difficult disorders. (Michael Joel Schrift, Doody's Review Service, February, 2011)


Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

Aorrng

Shopping Cart
Your cart is empty
Shopping cart
Mailing List